People with type 2 diabetes received a variety of glucose-lowering treatments: 20.1% were treated with diet only, 61.7% received oral glucose-lowering medication, 5.2% received insulin and 13.0% were treated with a combination of oral medication and insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.